Huang Jijun, Wang Yongxiang, Yang Jiandong, Feng Xinmin
Department of Spine Surgery, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou Jiangsu, 225001, P. R. China.
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2024 Nov 15;38(11):1367-1371. doi: 10.7507/1002-1892.202408026.
To explore early effectiveness of unilateral biportal endoscopy (UBE) technique in the treatment of migrated lumbar intervertebral disc herniation.
A retrospective analysis was conducted on 87 patients with migrated lumbar intervertebral disc herniation, who were treated with UBE technique between May 2021 and December 2022 and met the selection criteria. There were 55 males and 32 females, with an average age of 48.8 years (range, 29-74 years). The disease duration ranged from 2 to 23 months, with an average of 9.1 months. The surgical segments included 17 cases of L , 32 cases of L , and 38 cases of L , S . According to Lee's classification criteria, there were 12 cases of type 1, 17 cases of type 2, 37 cases of type 3, and 21 cases of type 4. The operation time, length of hospital stay, and complications were recorded. The visual analogue scale (VAS) score was used to assess the degree of low back and leg pain before operaion and at 3 days, 3 months, 6 months, and 12 months after operation. The Oswestry disability index (ODI) was used to evaluate the lumbar spine function. At last follow-up, the modified MacNab criteria was used to evaluate the effectiveness. According to the preoperative migrated intervertebral disc classification, the patients were allocated into groups Ⅰ to Ⅳ. The differences in VAS score and ODI were compared.
All 87 patients successfully completed the operations. There was no nerve root injury, dural sac injury, or dural tear during operation. The operation time was (58.6±14.6) minutes and the length of hospital stay was (4.0±0.8) days. All incisions healed by first intention after operation. No symptomatic epidural hematoma occurred. All patients were followed up for 12 months. There were significant differences in VAS scores and ODI at each time point after operation when compared with those before operation ( <0.05). There were significant differences in VAS score at 3 days after operation when compared with that at 3, 6, and 12 months after operation ( <0.05). For ODI, except that there was no significant difference between 6 and 12 months after operation ( >0.05), there were significant differences between other time points after operation ( <0.05). At last follow-up, the effectiveness was rated as excellent in 66 cases, good in 13 cases, and fair in 8 cases according to the modified MacNab criteria, and the excellent and good rate was 90.8%. There was no intervertebral disc herniation recurred during follow-up period. There was no significant difference in VAS score and ODI among groups Ⅰ -Ⅳ before operation and at each time point after operation ( >0.05).
The UBE technique is safe and effective in the treatment of migrated lumbar intervertebral disc herniation, with a low complication rate and satisfactory early effectiveness.
探讨单侧双通道内镜(UBE)技术治疗移位型腰椎间盘突出症的早期疗效。
回顾性分析2021年5月至2022年12月期间采用UBE技术治疗且符合入选标准的87例移位型腰椎间盘突出症患者。其中男性55例,女性32例,平均年龄48.8岁(范围29 - 74岁)。病程2至23个月,平均9.1个月。手术节段包括L₄ 17例、L₅ 32例、L₅ - S₁ 38例。根据Lee's分类标准,1型12例,2型17例,3型37例,4型21例。记录手术时间、住院时间及并发症情况。采用视觉模拟评分法(VAS)评估术前及术后3天、3个月、6个月和12个月时腰腿痛程度。采用Oswestry功能障碍指数(ODI)评估腰椎功能。末次随访时,采用改良MacNab标准评估疗效。根据术前移位椎间盘分类将患者分为Ⅰ至Ⅳ组,比较VAS评分和ODI的差异。
87例患者均成功完成手术。术中无神经根损伤、硬脊膜囊损伤或硬脊膜撕裂。手术时间为(58.6±14.6)分钟,住院时间为(4.0±0.8)天。术后所有切口均一期愈合。未发生有症状的硬膜外血肿。所有患者均随访12个月。术后各时间点的VAS评分和ODI与术前比较差异有统计学意义(P<0.05)。术后3天的VAS评分与术后3个月、6个月和12个月比较差异有统计学意义(P<0.05)。对于ODI,除术后6个月和12个月之间差异无统计学意义(P>0.05)外,术后其他时间点之间差异有统计学意义(P<0.05)。末次随访时,根据改良MacNab标准,疗效评定为优66例,良13例,可8例,优良率为90.8%。随访期间无椎间盘突出复发。术前及术后各时间点Ⅰ - Ⅳ组的VAS评分和ODI差异无统计学意义(P>0.05)。
UBE技术治疗移位型腰椎间盘突出症安全有效,并发症发生率低,早期疗效满意。